Clinical trials recruiting for Metastatic Solid Tumors
Phase breakdown
Drugs and treatments being studied
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 3 |
| Minnesota | 3 |
| Texas | 3 |
| Virginia | 3 |
| Florida | 2 |
| Massachusetts | 2 |
| New York | 2 |
| Tennessee | 2 |
| Colorado | 1 |
| Connecticut | 1 |
| District of Columbia | 1 |
| Georgia | 1 |
Top cities
Self-screener
Recruiting trials
- A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
- A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors
- The Sarah Nanotechnology System for Treatment of Advanced Metastatic Solid Tumors Using Hyperthermia.
Related conditions
Trials recruiting for Metastatic Solid Tumors often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Metastatic Solid Tumors trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.